Watson Pharmaceuticals CEO: Reinvestment better for stockholders right now Watson Pharmaceuticals CEO sees reinvestment of capital into expanding business is better for stockholders right now. Watson Pharmaceuticals CEO Paul Bisaro talked of the company's intent to expand its "brand" business as opposed to generic business.
News For WPI From The Last 14 Days
Check below for free stories on WPI the last two weeks.
